Profit-Taking Hits Moderna Stock After mRNA-1010 Wins Unanimous FDA Panel Backing Decision due Aug 5, 2026. Potential 2026–27 launch. Credit: Philip Keith/Bloomberg Subscribe now Already have an account? Sign in.
